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Abstract
Anthelmintic resistance is a major threat to current measures for helminth control in humans and animals. The introduction
of anthelmintic vaccines, as a complement to or replacement for drug treatments, has been advocated as a preventive
measure. Here, a computer-based simulation, tracking the dynamics of hosts, parasites and parasite-genes, shows that,
depending on the degree of host-population mixing, the frequency of totally recessive autosomes associated with
anthelmintic resistance can follow either a fast dynamical regime with a low equilibrium point or a slow dynamical regime
with a high equilibrium point. For fully dominant autosomes, only one regime is predicted. The effectiveness of
anthelminthic vaccines against resistance is shown to be strongly influenced by the underlying dynamics of resistant
autosomes. Vaccines targeting adult parasites, by decreasing helminth fecundity or lifespan, are predicted to be more
effective than vaccines targeting parasite larvae, by decreasing host susceptibility to infection, in reducing the spread of
resistance. These results may inform new strategies to prevent, monitor and control the spread of anthelmintic resistance,
including the development of viable anthelmintic vaccines.
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Introduction
Under favorable ecological conditions, the use of anthelmintic
drugs may result in the spread of drug resistant parasite strains that
spontaneously occur or are imported into parasite populations
[1,2,3]. Conventionally, alleles with frequency greater than 1% in
a population are considered wild types, while those with frequency
below 1% are considered mutants [4]. The spread of alleles is
generally influenced by host-parasite regulatory mechanisms, such
as density dependence [5], by the genetic make-up of resistant
strains, and by the mechanism of transmission [6]. Genetics and
transmission dynamics of the parasites play key roles in the
emergence and spread of new strains (e.g. the transmission of
packets of infectious larvae can explain the fast spread of fully
recessive resistance to levamisole in the sheep nematode Haemoncus
contortus [6]). The combined effects of these contributing factors
remain largely unexplored.
The main control strategy against helminths is periodic
chemotherapy using anthelmintics (e.g. albendazole, mebendazole,
pyrantel pamoate and levamisole) [7,8,9,10,11]. Concerns about
the variable efficacy of these drugs and the possible development of
resistance [3,10,12] have stimulated efforts to develop new methods
of control, including vaccines [13,14,15,16,17]. For instance,
Ancylostoma secreted protein-2 of Necator americanus (Na-ASP-2)
[16,18,19,20] has been shown to protect dogs and hamsters from
infection when challenged with larvae of human hookworm. Other
existing or candidate vaccines against helminths rely on different
biological mechanisms. For example, Cathepsin L from the
monoecious sheep parasite Fasciola hepatica reduces F. hepatica egg
production and egg viability [21], while Anti-H-gal-GP interferes
with the digestive process in H. contortus leading to premature death
of the parasites [22]. None of these vaccines provides or is likely to
provide full protection against helminth infection and morbidity
(model I or ‘‘leaky’’ vaccine [23,24]). As a result, in most cases it will
still be necessary to treat individuals for existing infections using
anthelmintics. By reducing the frequency of drug treatment (and the
resulting selection pressure) and the reproductive rate of the
parasites, vaccines can potentially decrease the spread of alleles
associated with drug resistance.
Here a computer-based simulation tracking the dynamics of
hosts, parasites and parasite-genes is used to study the transition of
a gene associated with drug-resistance from mutant (or imported)
to wild type in a population of dioecious helminths, and the
potential contribution of anthelmintic vaccines to containing the
spread of autosomal genes associated with drug resistance. Central
to this study are: i) the role of between-host mixing, and of the
associated degree of parasite inbreeding, in shaping the dynamics
of fully dominant and fully recessive anthelmintic resistance; ii) the
impact of vaccines targeting different stages and biological
functions of helminths and their influence on the rate of selection
imposed by external chemotherapeutic interventions; and iii) the
impact of parasite genetics and host-host transmission patterns on
vaccine performance. Due to its epidemiological relevance human
hookworm is used as a case-study here.
Hookworms (Ancylostoma duodenale and Necator americanus)
are the most widespread human intestinal parasites. They are
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the tropics and sub-tropics. Adult worms live and mate in the small
intestine of humans. Eggs exit the body in the feces and
contaminate the soil, where larvae emerge and molt. The infective
larvae are capable of penetrating the skin of a new host. The
larvae migrate through the host tissue and blood vessels reaching
lungs and trachea, from where they are swallowed before maturing
into adults in the small intestine [11].
Results
Ecological and epidemiological scenario
The simulation reproduces the following scenario (Figure 1).
Initially, only a subgroup of an endemically infected human
population carries parasites with the gene of anthelmintic
resistance. The introduction of resistant parasites in this subgroup
can be due to human mobility (e.g. immigration) or infection from
a common source. The subgroup is assumed to be the focus, from
which drug resistant parasites may begin to spread to the general
population. Because inbreeding may play an essential role in the
spread of drug resistance (5), individual hosts in the focus are
assumed to belong to the same infective contact network,
nevertheless they do not need to live in close proximity, i.e to
belong to the same household. Infective contacts, i.e. the
transmission of parasites between hosts, typically occur when
hosts spend time in a common place with poor or no sanitations
and whose environmental conditions are suitable for egg hatching,
larvae molt and host penetration. Ecological examples include:
schoolchildren attending the same school, workers of a plantation
or mine without appropriate sanitation facilities. Hosts in the focus
are assumed to be exposed, on average, to the same risk of
infection and to carry, on average, the same parasite burden as the
general population in their community. They may mix homoge-
neously with the general population or mix preferentially with
other hosts belonging to the focus (assortative mixing) [25,26]. For
instance workers in a particular plantation might be infected by
and infect preferentially their co-workers, but also family members
(e.g. school-age children) and other members of their (hyper-
endemic) community. The average proportion (r) of parasites that
plantation workers acquire from and transmitted to co-workers is
inversely related to the degree of mixing of this subpopulation (the
focus) with the rest of the community. No assumption is made on
whether parasite transmission occurs in bundles or one at a time,
but from the same source (e.g. the loamy soil area surrounding an
infected household, a school or a plantation).
Two alternative interventions are considered and compared in
their impact on drug resitance: annual treatment with anthelmin-
tic drugs or, every five years, anthelmintic treatment followed by
anthemintic vaccination. The epidemiological variable of interest
is FA, the frequency of resistant alleles in the general population,
i.e the population that does not belong to the initial focus of
resistance. Here FA is used to measures the spread of resistance, as
a function of time and population mixing.
The key simulation parameters are reported in Table 1. The
basic reproductive number R0 is equal to 3, the adult worm
mortality rate m is equal to 0.2. The parameters of the (negative-
binomial) distribution of worms at equilibrium are the mean worm
burden W=20 and the clumping parameter k=0.34 [27]. This
study assumes no acquired immunity to hookworm infection.
Anthelmintic drugs are assumed to kill 80% [28] of susceptible
worms and 1% of resistant worms and to be administered every 1
year or, if combined with vaccine, every 5 year. The vaccine
efficacy ranges from 10% to 90%. The vaccine duration T is equal
to 5 years.
The face validity of the model was shown by simulating the
epidemiological scenarios of published hookworm re-infection
studies [29][30][31][32] and comparing model predictions with
the observed dynamics. A substantial agreement was found
between observed and simulated re-infection time-scales (see
Supplementary Materials and Methods S1).
The dynamics of resistant alleles
When resistance is associated with a rare recessive allele, there
are two alternative dynamical regimes associated with the spread
of resistant alleles outside the primary focus of resistance (Figure 2,
A–B and Figure S1) depending on whether the proportion r of
transmission occurring from hosts to hosts within the focus, which
is associated with parasite inbreeding, is below or above a
‘‘threshold value’’. For the parameter values in table 1, the
threshold value is 69% (range: 66%–71%) (see also Supplementary
Materials and Methods S1). If r is less than 69%, low degree of
inbreeding, the allele frequency in the parasite population grows
fast and plateaus (to 0.27%–0.30% for the parameter values in
table 1) within 2–10 years since start of treatment. The positive
selection pressure exerted by the drug cannot compensate for the
reduction in mating (due to mortality of drug susceptible parasites)
Figure 1. Nested Host-Parasite-Gene populations. A) A host may carry susceptible and resistant parasites, a parasite can be either homozygous
or heterozygous for the gene associated with resistance; B) Euler diagram of the host population. Alleles associated with drug resistance are initially
concentrated within a sub-set (focus) of the host sub-population (target) that receives either annual chemotherapy or chemotherapy and vaccine
every T (e.g. every 5) years.
doi:10.1371/journal.pone.0010686.g001
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the resistant phenotype. If r is higher than 69%, indicating a high
degree of inbreeding, a long initial phase (6–12 years) of slow
growth is followed by a short phase of fast growth and then by a
plateau, with the allele frequency reaching up to 1.7% 20 years
after the start of treatment. If r is about 69% a quasi-linear growth
of the allele frequency is observed from year 2 to year 10. A non-
monotonic relationship between the allele frequency at time
T=20 years and r is observed, with a maximum allele frequency
observed for r=85%.
The frequency of resistant alleles within the focus (see Figure
S2): i) decreases monotonically with time and plateaus if r,69%;
ii) declines by about 25% within the first three years and grows
thereafter if r=69%; or iii) grows quasi-monotonically if r.69%.
To disentangle the effect of genetics and mixing from other
aspects of the model, such as density dependence and population
structure, and to understand the origin of the two-regime behavior
of recessive resistant genes, a simple deterministic model of allele
transmission and spread, based on a birth-death process [33],
regulated by Mendel’s laws [4] and subject to heterogeneous
mixing, was developed (See Supplementary Materials and Methods S1).
The deterministic model results suggest that (Figure S3), for
sufficiently high levels of selective pressure and depending on the
balance between production and dissemination of drug resistant
Table 1. Baseline parameters for the model.
Parameter Values Description Reference
ag,sus 80% Anthelmintic efficacy in susceptible worm populations [28]
ag,res 1% Anthelmintic efficacy in resistant worm populations Present study
Ro 3 Basic reproductive number Present study, based upon [1]
m 0.2/year Worm mortality rate [1]
W 20 worms/person Mean worm burden (intensity of infection) Present study
k 0.34 Aggregation parameter (or clumping parameter) [27]
V 0 Strength of naturally acquired immunity Present study, based on: [1][11][27]
v ,0.1/year Immunological memory Present study, based on: [1][11][27]
doi:10.1371/journal.pone.0010686.t001
Figure 2. Allele frequency in worms outside of the primary focus of resistance. Resistance can be fully recessive (A–B) or fully dominant (C–
D). Annual chemotherapy is administered to 50% of the host population and no vaccination. Simulation parameters in Table 1. A) If resistance is a
recessive character the allele frequency follows two different time-dynamics depending on the the degree of host-population mixing r: i) for r
smaller than 69%, it grows fast and plateaus at a level inversely related to the value of r; ii) for r equal to or larger than 69%, a slow initial growth is
followed by an accelerated growth. B) Non-monotonic relation between the allele frequency after 20 annual chemotherapy rounds and r. The
maximum allele frequency is observed when r is equal to 85%. C) If resistance is a dominant character, the allele frequency grows at a rate inversely
related to r. D) Negative monotonic relationship between the allele frequency after 20 annual chemotherapy rounds and r. The maximum allele
frequency is observed when r is equal to 1.99% (homogeneous mixing case).
doi:10.1371/journal.pone.0010686.g002
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two-regime behavior controlled by the parameter r, consistently
with the results of the stochastic individual-based model used in
this study.
When resistance is associated with a fully dominant allele,
invasion and strain replacement are steady processes, with a step-
growth of the allele frequency (Figure 2, C–D). The degree of
parasite inbreeding within the focus determines the rate at which
the resistant strain will spread. Unlike in the case of recessive
alleles, assortative mixing of resistant alleles slows the rate of
invasion. For instance, if r=92% the population invasion is
almost four times slower than if the host-population mixes
homogeneously, with respect to transmission, with the general
population.
The dynamics of resistant alleles is essentially driven by their
genetic dominance, by the degree of host-population mixing, and
by the selective pressure exerted by drugs. The spread of resistance
outside the initial focus is driven by two competing actions:
production of offspring with the drug-resistant phenotype and
dissemination of the drug-resistant offspring outside the initial
focus. High transmission clustering increases the first, while
reducing the second.
The effect of vaccination
Vaccines can change the dynamics of resistant alleles (Figure S4)
by stopping or slowing replacement of the susceptible strain with
the resistant strain. Figure 3 presents the population-level vaccine
effectiveness VE (see eq. 6.1) as a function of the allele dominance
and of the biological target of the vaccine. Here density-
dependence acts on reproduction. VE increases with gene
dominance and is higher when drug-resistance is associated with
a fully dominant gene. VE is higher when the vaccine acts by
increasing parasite mortality and by reducing parasite fecundity
than when it acts by reducing host-susceptibility.
In the fully recessive case, VE increases with r, in all situations.
In the fully dominant case VE increases with r, if the vaccine
reduces host susceptibility and, slightly decreases with r, if the
vaccine reduces female parasite fecundity; VE is virtually
independent of r, if the vaccine reduces the parasite lifespan.
The results for density dependence acting on parasite establish-
ment (Figure S5) are qualitatively similar in the recessive case,
while they differ in the dominant case, for VE increases with r,i f
the vaccine reduces the parasite lifespan.
The greatest net gain from combining vaccines with different
modes of action (see for example Figure 4) is obtained when the
Figure 3. Population-level vaccine effectiveness (VE), assuming that density dependence acts on the fecundity of established
parasites, and that 50% of the host population is effectively vaccinated (Simulation parameters in Table 1). Vaccines can reduce the
host susceptibility to infection (A–B), by a proportion VS, or the female parasite reproductive rate (C–D), by a proportion VR, or the parasite lifespan
(E–F), by a proportion VM. Vaccines reducing the parasite fecundity and vaccines reducing the parasite lifespan are more efficacious than vaccines
reducing host susceptibility by the same proportion. Low reductions (,50%) in female reproductive rate have marginally higher impact than equal
proportional reductions in adult worm lifespan. The impact on recessive alleles (A–C–D) grows with r, the degree of host-population mixing. The
impact on dominant alleles increases with (B), decreases with (D) or is independent of (F) r, depending on the biological action of the vaccine.
doi:10.1371/journal.pone.0010686.g003
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different vaccines (say s and r) are found to be sub-additive:
(1{VE(szr)w 1{VE(s) ðÞ 1{VE(r) ðÞ
Sensitivity analysis
The sensitivity of the results to model parameters and
assumptions was assessed through univariate and multi-variate
analysis, as reported in Tables S1, S2, S3, S4. The spread of
anthelmintic resistance is favored by high drug coverage,
overdispersion of parasites, and a high basic reproductive number.
The level of transmission clustering required for the transition
from fast to slow dynamics in recessive populations decreases as
drug coverage, overdispersion and the basic reproductive number
increase. On the other hand, it increases if there is a residual drug
susceptibility associated with the resistant phenotype.
The spread of resistant genes is most efficient in high prevalence
settings, if the host life expectancy is significantly longer than the
waning time of acquired immunity (if any) and if density-
dependent constraints act on worm establishment rather than
fecundity.
Reducing the frequency of drug treatment lowers the frequency
of resistant recessive alleles only if r.69%, while it lowers the
frequency of dominant alleles independently of the value of r.
The allele dynamics are sensitive to relative susceptibility of
worm strains to anthelmintics, here measured as the ratio between
the effectiveness of anthelmintics on the most susceptible and on
the least susceptible strains. For recessive alleles, the results are
more sensitive to the relative susceptibility when r is above 69%.
The initial density of resistant worms in the focus has
repercussions on the rate at which alleles spread in the
population. Recessive alleles may go extinct and dominant
alleles may temporarily decrease in number, if their frequency
and numbers are too low, due to a low probability of worm
mating and to phenotype inheritance constraints (due to
Mendel’s laws).
Higher vaccine coverage increases the protective effect if the
vaccine reduces susceptibility to infection while it has relatively
little impact if the vaccine reduces fecundity or increases worm
mortality, provided that the focus of resistance is fully vaccinated.
Increasing the basic reproductive number increases the impact of
the vaccine relative to chemotherapy. This increase is small for
highly efficacious vaccines, but rather large for low efficacious
vaccines. Increasing parasite overdispersion also increases the
impact of the vaccine relative to chemotherapy alone.
The impact of vaccines is marginally higher if the density
dependence process acts on establishment rather than acting on
fecundity (Figure S5).
Discussion
Genetic dominance and patterns of contact between hosts are
major determinants of the dynamics of anthelmintic resistance
both in the presence and in the absence of vaccination.
Under the model assumptions, depending on selection pressure
and on host-population mixing, the dynamics of recessive genes
can be very fast and lead to equilibrium between resistant and
susceptible parasite strains or may be very slow (and possibly go
undetected for many years) before entering a phase of fast growth.
Because the existence of fast and slow allele dynamics implies that
different levels of mixing result in different time-scales for the
diffusion of recessive allele, it can be argued that, in a real-world
setting, characterized by a highly heterogeneous contact network
structure, recessive resistance may spread through sudden jumps
preceded and followed by long periods of equilibrium and
coexistence with susceptible strains. Unlike the case of dominant
genes, the spread of recessive genes is non-monotonically related
to the degree of isolation of the focus from which resistant parasites
spread to the general population. Validity and robustness of this
result were independently tested using a genetically-structured
deterministic model of helminth transmission (see Supplementary
Figure 4. Impact of multi-target vaccines. Vaccines simultaneously reducing fecundity (VR) and susceptibility (VS) (panels A–B) or fecundity,
susceptibility, and parasite life-span (VM) (panels C–D) have the greatest potential. In this example, it is assumed that the vaccine reduces by the same
proportion female worm fecundity, host susceptibility, and parasite lifespan. A and C refer to recessive alleles, B and D refer to dominant alleles.
doi:10.1371/journal.pone.0010686.g004
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monotonic relation between spread of recessive resistant genes and
mixing were observed for a range of key biological parameters (e.g.
basic reproductive number, natural parasite mortality rate,
endemic mean worm burden and initial prevalence of resistant
genes) and intervention-related parameters (e.g. coverage and
drug-induced parasite mortality rate). Unlike in the main model,
the frequency of resistant alleles does not usually plateau, as
observed in the fast dynamical regime within the main model, but
it rather grows for several decades at a very slow rate. This is due
to the fact that the simple deterministic model does not track
individual hosts and therefore does not account for reductions in
the mating probability due to within-host segregation of same-sex
parasites (i.e. some hosts will harbor same-sex parasites, not able to
reproduce). In general, individual-based models, such as the one
used in this study, are more suited to capture the dynamical
features associated with within-host parasite segregation.
The dynamics of dominant alleles initially clustered within a
small proportion of individual hosts are not qualitatively affected
by the specific patterns of transmission.
Vaccines capable of reducing the adult parasite life span have
the greatest potential to prevent the spread of resistant genes,
followed by those reducing fecundity and susceptibility. However,
vaccines that only reduce fecundity would appear rather
unattractive to individuals, as they provide no direct benefit to
those who are vaccinated. A multi-target vaccine, combining
different single-target vaccines acting on different biological
functions and life stages of the parasite, e.g. susceptibility to larva
migration, reproduction and life span, would prove the most
effective option, especially if none of the single-target vaccines are
highly efficacious, and would prove more robust against antigenic
drift [34]. These findings may elicit and contribute to scientific
debates and operational decisions on the development and use of
vaccines against helminthes and other macro-parasites.
The results presented in this study assume that resistant parasites
spread to the general host population from a group of hosts
representative of, but generally not mixing homogeneously with, the
general host population. Under endemic equilibrium this implies a
‘‘zero-sum’’transmission between the group of initial carriers (focus of
resistance) and the general population. Thisassumption may not hold
if resistant parasites are clustered in super-spreaders, i.e. individuals
with medium to high parasite burden adopting behaviors that
promote parasite spread (e.g. open field defecation), in which case
recessive genes may spread faster than predicted in this study.
As with all models, this framework only provides a crude
representation of hookworm transmission dynamics and could be
expanded to capture additional features, such as acquired
immunity and seasonality. However, to date, there is no clear
understanding of and agreement on the role played by
immunological processes in human hookworm infection
[8,11,35,36]. Age-intensity curves suggest that, at a population
level, the effect of acquired immunity is weak and short-lived [11].
Seasonal effects have not been included in the model because the
relevant time scales of the model (frequencies of treatment and
vaccination, and the parasite and host life-spans) are equal to or
longer than one year, nevertheless seasonal phenomena, such as
rain and drought, are likely to have an impact on the quantitative
estimates provided here.
The model is built on our current understanding of helminth
epidemiology [7,9,10,14,16,37,38,39] and its outputs are consis-
tent with the re-infection time-scales observed in comparable field
studies [29,30].
However, factors such as the number of genes involved in
drug resistance, the way the genes interact, e.g. dominance,
complementary action, heterogeneity, epistasis, and any poten-
tial fitness costs associated with resistance, e.g. due to gene
pleiotropy [4], are likely to affect the quantitative predictions of
the model.
The qualitative results presented here would hold with the
addition of further biological and ecological complexity and may
be sufficiently general to be valid for other dioecius macroparasitic
pathogens, e.g. Plasmodium falciparum, characterized by density
dependence, transmission heterogeneity and clustering [17,40,41],
although, to date, there is no clear evidence of inbreeding for
malaria [42].
Better, evidence-based, information on density-dependence,
immunity, genetic proximity of in-host parasites and genetic
determinants of predisposition to infection would allow the
development of more detailed models and provide more robust
estimates.
From a general standpoint, this work illustrates the role of host-
to-host transmission heterogeneity on anthelmintic dynamics and
suggests that vaccines may need to target more than one parasite
life-stage or biological function to help control macro-parasitic
diseases, in the absence of more radical and effective interventions
(e.g. ensuring human access to clean water, sanitations, shoes, etc.)
capable of altering the host-parasite ecology for the benefit of the
hosts.
Materials and Methods
A stochastic discrete-time and discrete-event model, combining
meta-population-based and individual-based approaches, was
developed to explore the dynamics of anthelmintic resistance
and the impact of vaccination on resistant strains. The simulation
tracks the gene inheritance within parasite meta-populations,
defined by sex and genotype, harbored by individual hosts, which
are characterized by age, susceptibility to helminth infection, host-
to-host transmission patterns, and genotype- and sex-specific
parasite burden.
1. Model Structure
The model simulates the distribution and dynamics of parasites
harbored in individual hosts and of genes, associated with
drug resistance, within the parasite population. Let W(t)~
fW1(t)::::WN(t)g denote the vector of individual worm burdens
in a host (e.g. human) community at time t. Let Ar t ðÞ ~
P N
j~1
P 2
s~1
P 3
g~1
g{1 ðÞ Wj,s,g(t) and FAr t ðÞ ~Ar t ðÞ
,
2
P N
j~1
P 2
s~1
P 3
g~1
Wj,s,g(t) be the number of copies and the frequency of the allele
associated with worm resistance within a worm population hosted
by a host community of size N at time t, with s=1 for female
worms and s=2 for male worms. Wj,s,g(t) is the sex s and genotype
g specific worm burden of individual j, Wj(t)~
P 3
g~1
Wj,1,g(t)z
Wj,2,g(t) the total worm burden of individual j and
W(t)~
P N
j~1
P 3
g~1
Wj,1,g(t)zWj,2,g(t)
    
N the mean worm burden.
The rate of acquisition of new worms in a host depends on the
basic reproductive number of the worm R0 (the number of female
parasites produced by an average female parasite, when there are
no density dependent constraints acting anywhere in the life-cycle
of the parasite [1]), a community density-dependent constraint f(:)
[33,43,44], known as negative density-dependence (reducing
female parasite fecundity as the number of parasites within a host
increases the rate of acquisition of new parasites as the number of
parasites within a host increases, consistently with empirical
Resistant Helminths & Vaccines
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new worms ~ h hj [39].
Then, f(:) takes the form:
f R
j,g c,W ðÞ ~
1
N
X N
i~1
Zj,iCi,g
P 3
gl~1
Wi,1,gl
P 3
g0~1
Wi,1,g0zWi,2,g0
  
"# c ð1:1Þ
Where
Zj,i~
rN=Nk
1{r ðÞ N= N{Nk ðÞ
1{r ðÞ N= N{Nk ðÞ
N{ 2{r ðÞ Nk ðÞ N
.
N{Nk ðÞ
2
if i,j [ Focus
if i 6[Focus; j [ Focus
if i[ Focus; j 6[ Focus
if i 6[ Focus; j 6[ Focus
8
> > > > <
> > > > :
ð1:2Þ
This choice of Zj,i preserves the negative binomial distribution of
parasites across the host population while ensuring that a fraction
r of all the infections occurring within the focus is determined by
the offspring of worms harbored by individual hosts in the
focus.
Ci,g~
P 3
g0,g00~1
Wi,1,g0Mg,g0,g00Wi,2,g00
P 3
gl~1
W
i,1,gl
 !
P 3
gp~1
Wi,2,gp
 ! if
P 3
gl~1
Wi,1,gl
 !
P 3
gp~1
Wi,2,gp
 !
w0
0 if
P 3
gl~1
Wi,1,gl
 !
P 3
gp~1
Wi,2,gp
 !
~0
8
> > > > > > > > > > <
> > > > > > > > > > :
ð1:3Þ
where
M1,g0,g00~
10 :50
0:50 :25 0
00 0
0
B B @
1
C C A; M2,g0,g00~
00 :51
0:50 :50 :5
10 :50
0
B B @
1
C C A;
M3,g0,g00~
00 0
00 :25 0:5
00 :51
0
B B @
1
C C A
ð1:4Þ
are determined by the Mendelian inheritance laws [4] and express
the likelihood of obtaining genotype 1, 2 or 3 by crossing
genotypes g9 and g0.
Lj t ðÞ ~1{V
X t
d~tbirth
X 3
g0~1
Wi,1,g0 d ðÞ zWi,2,g0 d ðÞ
   .
exp v t{d ðÞ ½  ð 1:5Þ
is the proportional reduction of susceptibility to infection due to
acquired immunity [1]. With V representing the strength of
acquired immunity and v{1 the average immunological memory.
The adult worm mortality is m. Similarly, if density dependence
acts upon the rate of establishment of adult worms
f E
j,g e,W ðÞ ~
e
{e
P 2
s0~1
P 3
g00~1
Wj,s0,g00
 !
N
X N
i~1
Zj,iCi,  g g
X 3
g0~1
Wi,1,g0
0
@
1
A ð1:6Þ
where c is the power-law exponent and e is the rate of exponential
decay.
Thus the average rate at which new worms of genotype g and
sex s (s=1 or s=2) are acquired by host j is given by:
QSm R0hjLjfj,g (QS is the fraction of worms of sex s, Q1zQ2~1)
and are cleared in host j at rate mj, the parasite death rate.
If DWj,s,g t ðÞdenotes the genotype- and sex-specific change in
worm burden in individual j occurring between time t and tzdt
(dt being the time-step of the simulation) then an individual’s worm
burden dynamics are described by the equations:
DWj,s,g t ðÞ ~~ p pj,s,g t ðÞ {~ d dj,s,g t ðÞ
~ p pj,s,g t ðÞ *Poisson QSm R0hjLjIjfj,gdt
  
~ d dj,s,g t ðÞ *Binomial Wj,s,g t ðÞ ,1{e{md t   
ð1:7Þ
2. Endemic distribution of parasites
When hookworm is endemic in a community the ende-
mic distribution of individual worm burdens Wj~
P 3
g~1
Wj,1,gzWj,2,g
  
is best described by a negative binomial
distribution whereby relatively few people harbor most of the
parasites. This is built into the model by assuming that hosts have
different levels of susceptibility ~ h hj (~ h hj~hjLj and hj~~ h hj
.
Lj 0 ðÞ ).
Drawing the sex- and genotype-specific establishment rate
DWj,s,g t ðÞfor a host j from a Poisson distribution with a mean
equal to ~ h hjDWj,s,g t ðÞ , the susceptibility ~ h hj from a Gamma
distribution with variance 1/k and describing the dynamics of
the mean parasite burden W with an immigration-death process
(with a birth rate
1
2
m R0hjLjf R
j,g c,W ðÞ and a death rate m), ensures
that, at equilibrium, the individual distribution of parasites can be
described by a negative binomial with mean W and variance
s2~Wz
W2
k
[8,43,45]. The initial value of Lj 0 ðÞ is calculated as
a function of the age and worm burden Wj of individual j. In the
absence of drug treatment and ignoring possible seasonal
variations (since the lifespan of a hookworm typically exceeds
one year) and when the infection is at endemic equilibrium, the
total worm burden in the community is constant. The parameter c
and e are entirely determined by R0, k, W and by the choice
of the appropriate functional relationship (either (1.1) or (1.6)).
They can be derived by imposing the stationarity condition
P N
i~1
DWi t~0 ðÞ ~0 [8]. Because the pre-intervention worm burden
is assumed to be the same inside and outside the focus, the
stationarity condition implies that the transmission from and to the
focus is a stochastic process with expectation value equal to zero
(zero sum game).
3. Demographic structure and age-intensity relationship
Individuals in the model live from 0 to 50 years and die
thereafter. The mean worm burden increases as hosts become
older and plateaus after the age of 20 [11].
4. Chemotherapy
If chemotherapy is introduced at time tc the worm burden of
treated individuals will change as:
Wj,s,g(tc)?Wj,s,g(tc){~ b bj,s,g ð4:1Þ
~ b bj,s,g*Binomial Wj,s,g tc ðÞ ,ag
  
ð4:2Þ
ð1.2Þ
ð1.3Þ
ð1.5Þ
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an individual harboring Wj,s,g(tc) worms at time tc and ag is the
probability that an adult worm of genotype g (which can be
susceptible or resistant) is killed by chemotherapy.
5. Vaccination
Three different types of vaccine are considered:
i) A vaccine reducing the individual susceptibility to infection in
host j with susceptibility hj at time t by a proportion VSj t ðÞ .
Following vaccination, susceptibility to infection in host j
becomes:
hj?hj 1{VSj t ðÞ
  
ð5:1Þ
ii) A vaccine reducing the female worm reproductive rate, in
host j with susceptibility hj at time t, by a proportion
VRj t ðÞ .
Cj,g?Cj,g~
1{VRj t ðÞ
  
P 3
g0,g00~1
Wi,1,g0 Mg,g0,g00 Wi,2,g00
P 3
gl~1
W
i,1,gl
 !
P 3
gp~1
Wi,2,gp
 ! if
P 3
gl~1
Wi,1,gl
 !
P 3
gp~1
Wi,2,gp
 !
w0
0 if
P 3
gl~1
Wi,1,gl
 !
P 3
gp~1
Wi,2,gp
 !
~0
8
> > > > > > > > > > <
> > > > > > > > > > :
ð5:2Þ
iii) A vaccine reducing the mean worm lifespan by a proportion
VMj t ðÞ , and therefore increasing the parasite mortality rate:
mj?mj
 
1{VMj t ðÞ
  
ð5:3Þ
The vaccine efficacy (called V if does not refer only to a specific
type of vaccine) wanes exponentially so that, on average,
Vt ðÞ ~V 0 ðÞ e{t=T,a n dw h e r eT is the average duration of
protection and, V 0 ðÞis the direct proportional reduction in
susceptibility to infection (VS(0)), female worm reproductive
rates (VR(0))o rw o r ml i f e s p a n( VM(0)) that would be measured
in a population in the absence of density dependent effects or
waning of vaccine efficacy. Waning is implemented in the model
by allowing ‘‘individual vaccine protection’’ to fail (i.e. to
change from VS 0 ðÞor VR 0 ðÞto zero) at any one time step dt
with probability dt=T. Alternative mechanisms, such as a
gradual reduction of individual protection (e.g. VSj h,t ðÞ ~
VSj h,0 ðÞ e{t=T) were also explored but did not substantially
affect the results.
6. Vaccine Effectiveness
The vaccine effectiveness VE is defined as the vaccine-induced
proportional reduction of the frequency of the allele associated
with drug resistance, within the human population of interest, over
a period Tf
VE~1{
P
Tf
t~t1V
FAr t,V ðÞ
P
Tf
t~t1V
FAr t,U ðÞ
ð6:1Þ
where FAr t,V ðÞ and FAr t,U ðÞ are the frequencies of the allele
associated with resistance, in the presence and in the absence of
vaccination (V stands for vaccinated and U stands for
unvaccinated). The first vaccination round starts at time
t1V~0.
7. Simulation
The model was used to simulate the effect of chemotherapy
alone and chemotherapy in combination with a vaccine allocated
to 50% of the whole population.
The initial frequency of resistant alleles is equal to 1% (a
borderline scenario between ‘‘mutant’’ and ‘‘wild’’) and is
clustered in 1.99% of the human population (equal to the
2pqzq2 term from the Hardy-Weinberg equation p2z2pqzq2),
to increase the mating probability of worms carrying the resistant
gene. The proportion of transmission happening within this initial
cluster (focus) of resistance r ranges from 1.99% (random mixing)
to 92% (highly heterogeneous mixing). The simulation reproduces
the effects of annual chemotherapy treatments as well as the effects
of combined chemotherapy and vaccination, administered every T
years, on susceptible and resistant worms and on the underlying
allele populations, over a 10-year period.
The mathematical relationship between host age and mean
worm burden [11] is consistent with a very weak and rapidly
waning naturally acquired immunity, with strength V,0.003 and
immunological memory 1/v,3 years. For the purposes of the
baseline simulation, and without loss of generality, no acquired
immunity to hookworm infection was assumed, nevertheless the
impact of the naturally acquired immunity on the outcomes of this
study was assessed as a part of the sensitivity analysis.
For each scenario, a mean statistic over 1,000 realizations, each
of which involves 10,000 individuals followed over a period of 10
(or 20) years was computed. The demographic structure of the
population and the parasite epidemiology are assumed to remain
unchanged during the simulation. The time-evolution was attained
via synchronous updating of the worm burden of each individual
and of the force of infection at each run, assuming that
contemporaneous infective episodes involving different individuals
are independent. The time-step between two runs of the
simulation is dt=0.2 years. This is a trade-off between a high
resolution time-dynamics, requiring a time-step much smaller than
the average life span of the parasite (dt%1=m0), and the constraints
set by the Markovian structure of the model, which overlooks the
intermediate stages of the worm life-cycle (for hookworm, it takes
approximately 9–12 weeks for an egg deposited in the soil to
mature into a sexually mature adult [46]).
Supporting Information
Materials and Methods S1
Found at: doi:10.1371/journal.pone.0010686.s001 (0.11 MB
DOC)
Figure S1 Frequency of resistant alleles after 10 years of
chemotherapy. A) Reducing the frequency of treatment does not
reduce the frequency of recessive alleles, unless the focus of
resistance is highly isolated (r=92%). B) Reducing the frequency
of treatment always reduces the frequency of dominant alleles.
The frequencies of (C) recessive and (D) dominant alleles increase
with the relative susceptibility to drugs, defined as the ratio of the
probabilities of being killed by drugs for susceptible and resistant
worms. Baseline parameters are in Table 1 of the main paper.
Found at: doi:10.1371/journal.pone.0010686.s002 (4.92 MB TIF)
Figure S2 Frequency of recessive alleles within the focus.
(5.2)
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Figure S3 Results from a simple deterministic model. A) If the
anthelmintic associated rate of death is higher than 0.35 the allele
frequency follows two different time-dynamics depending on the
degree of host-mixing r: i) it grows fast and then very slow ii) a
slow initial growth is followed by an accelerated growth. B) Non-
monotonic relation between the allele frequency after 20 annual
chemotherapy rounds and r obtained for different values of d. The
difference in allele frequency between the two dynamical regimes
decreases as the selection-pressure-related parameter d increases.
Baseline parameters are in Table 1 of the main paper.
Found at: doi:10.1371/journal.pone.0010686.s004 (2.61 MB TIF)
Figure S4 Effect of vaccination on the dynamics of drug
resistance. In this example the vaccine reduces by a proportion
VR the average reproductive rate of female parasites. A) Recessive
case: the reduction in the spread of recessive resistant alleles
primarily depends on the efficacy of the vaccine (in this example,
the vaccine acts on female worm fecundity and r=85%). B)
Dominant case: the reduction in the spread of dominant recessive
alleles primarily depends on the reduction of the frequency of
treatment (in this example, every 5 years instead of every year).
Baseline parameters are in Table 1 of the main paper.
Found at: doi:10.1371/journal.pone.0010686.s005 (2.23 MB TIF)
Figure S5 Vaccine effectiveness (VE) when density dependence
acts on the establishment of new worms. Vaccines can reduce the
host susceptibility to infection (A–B), by a proportion VS, or the
female parasite fecundity (C–D), by a proportion VR, or the
parasite lifespan (E–F), or by a proportion VM. Vaccines reducing
the parasite fecundity and vaccines reducing the parasite lifespan
are more efficacious than vaccines reducing host susceptibility by
the same proportion.
Found at: doi:10.1371/journal.pone.0010686.s006 (6.01 MB TIF)
Table S1 Univariate sensitivity analysis: Threshold for transition
r from fast to slow dynamics of recessive alleles. The value of r,
estimated at baseline, is 69%. Intervals refer to maximum and
minimum r values. Impact of a vaccine reducing host suscepti-
bility for VS=50% and r. Intervals of maximum and minimum
percentage variation of vaccine impact VE, from baseline values
VE=18% (recessive) and VE=17% (dominant) observed when
parameter values vary within the given ranges. Baseline param-
eters are in Table 1 of the main paper.
Found at: doi:10.1371/journal.pone.0010686.s007 (0.04 MB
DOC)
Table S2 Multivariate Sensitivity Analysis: Variation of the
threshold for transition rfrom fast to slow dynamics of recessive
alleles. The value of r, estimated at baseline, is 69%. The density-
dependent parameters are chosen to fit the endemic equilibrium
data. Baseline parameters are in Table 1 of the main paper.
Found at: doi:10.1371/journal.pone.0010686.s008 (0.04 MB
DOC)
Table S3 Sensitivity analysis of the impact of a vaccine reducing
hostsusceptibility for VS=50% andr=69%. Intervalsof percentage
variation of vaccine impact VE, from baseline values VE=18%
(recessive) and VE=17% (dominant) observed when parameter
values vary within the given ranges. The density-dependence
parameters are chosen to fit the endemic mean worm burden W
Min and Max are the minimal and maximal percentage deviation
from the simulation results obtained using baseline parameters, when
density-dependent regulatory mechanisms act on parasite fecundity.
Baseline parameters are in Table 1 of the main paper.
Found at: doi:10.1371/journal.pone.0010686.s009 (0.04 MB
DOC)
Table S4 Sensitivity Analysis of the impact of a vaccine reducing
female parasite fecundity, for VR=50% and r=69%. Intervals of
percentage variation of vaccine impact VE, from baseline values
VE=18% (recessive) and VE=17% (dominant) observed when
parameter values vary within the given ranges. The density-
dependence parameters are chosen to fit the endemic mean worm
burden W. Min and Max are the minimal and maximal
percentage deviation from the simulation results obtained using
baseline parameters, when density-dependent regulatory mecha-
nisms act on parasite fecundity. Baseline parameters are in Table 1
of the main paper.
Found at: doi:10.1371/journal.pone.0010686.s010 (0.05 MB
DOC)
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